We are live on ! Find out more
AIM

Advantage Investment Management Portfolio holdings

AUM $128M
1-Year Est. Return 3.61%
This Fund
S&P 500
This Quarter Est. Return
-0.32%
1 Year Est. Return
+3.61%
3 Year Est. Return
+32.97%
5 Year Est. Return
+46.27%
10 Year Est. Return
AUM
$206M
AUM Growth
+$29.5M
Cap. Flow
+$31.4M
Cap. Flow %
15.23%
Top 10 Hldgs %
25.41%
Holding
952
New
83
Increased
224
Reduced
195
Closed
80

Sector Composition

Rank Sector Weight
1 Financials 4.52%
2 Technology 4.09%
3 Healthcare 3.6%
4 Consumer Discretionary 3.49%
5 Energy 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAW icon
651
Vanguard Materials ETF
VAW
$3.08B
$7K ﹤0.01%
+65
New +$7.23K
VOO icon
652
Vanguard S&P 500 ETF
VOO
$1.01T
$7K ﹤0.01%
37
-4,557
-99% -$878K
VOOV icon
653
Vanguard S&P 500 Value ETF
VOOV
$6.68B
$7K ﹤0.01%
+80
New +$7.27K
XHB icon
654
State Street SPDR S&P Homebuilders ETF
XHB
$1.53B
$7K ﹤0.01%
200
ATHX
655
DELISTED
Athersys, Inc. Common Stock
ATHX
$7K ﹤0.01%
240
+80
+50% +$3.11K
NRF
656
DELISTED
NorthStar Realty Finance Corp.
NRF
$7K ﹤0.01%
207
-293
-59% -$10.5K
TLN
657
DELISTED
Talen Energy Corporation
TLN
$7K ﹤0.01%
+400
New +$7.55K
RAX
658
DELISTED
Rackspace Hosting Inc
RAX
$7K ﹤0.01%
200
-100
-33% -$4.6K
NTI
659
DELISTED
NORTHERN TIER ENERGY LP CLASS A
NTI
$7K ﹤0.01%
300
ZINC
660
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
$7K ﹤0.01%
+592
New +$7.72K
PLL
661
DELISTED
PALL CORP
PLL
$7K ﹤0.01%
57
OREX
662
DELISTED
Orexigen Therapeutics, Inc.
OREX
$7K ﹤0.01%
140
ADC icon
663
Agree Realty
ADC
$9.5B
$6K ﹤0.01%
221
AEM icon
664
Agnico Eagle Mines
AEM
$85B
$6K ﹤0.01%
200
BTO
665
John Hancock Financial Opportunities Fund
BTO
$800M
$6K ﹤0.01%
209
CACI icon
666
CACI
CACI
$13.9B
$6K ﹤0.01%
70
CFR icon
667
Cullen/Frost Bankers
CFR
$10.2B
$6K ﹤0.01%
75
CPRX
668
DELISTED
Catalyst Pharmaceutical
CPRX
$6K ﹤0.01%
1,500
EWBC icon
669
East-West Bancorp
EWBC
$18.1B
$6K ﹤0.01%
132
FFIV icon
670
F5
FFIV
$23.5B
$6K ﹤0.01%
50
HUM icon
671
Humana
HUM
$44.1B
$6K ﹤0.01%
31
-100
-76% -$18.6K
ICF icon
672
iShares Select U.S. REIT ETF
ICF
$2.08B
$6K ﹤0.01%
138
IHE icon
673
iShares US Pharmaceuticals ETF
IHE
$1.64B
$6K ﹤0.01%
99
NVAX icon
674
Novavax
NVAX
$1.27B
$6K ﹤0.01%
25
-25
-50% -$4.39K
PBE icon
675
Invesco Biotechnology & Genome ETF
PBE
$287M
$6K ﹤0.01%
100

Similar funds

Advantage Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Advantage Investment Management held 952 positions worth $206M, up 17% from $176M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Advantage Investment Management deployed $31.4M of net new capital in Q2 2015, opening 83 new positions and adding to 224 existing holdings. Its largest new stake was iShares Floating Rate Bond ETF: 88,062 shares worth $4.46M.

By sector, the portfolio is most concentrated in Financials at 4.5% of assets, down from 4.6% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares US Industrials ETF, an estimated $3.55M trimmed.

  • Advantage Investment Management's largest Q2 2015 buy was iShares Floating Rate Bond ETF: 88,062 shares worth $4.46M.
  • Advantage Investment Management added most to First Trust Dorsey Wright Focus 5 ETF in Q2 2015, an estimated $4.18M increase.
  • Advantage Investment Management's biggest Q2 2015 reduction was iShares US Industrials ETF, cutting an estimated $3.55M.
  • Advantage Investment Management fully exited iShares Russell 1000 Growth ETF in Q2 2015, selling an estimated $820K.
  • Advantage Investment Management's ten largest holdings make up 25% of its $206M portfolio in Q2 2015.
  • Advantage Investment Management opened 83 new positions and closed 80 in Q2 2015.
  • Advantage Investment Management's portfolio value rose 17% quarter-over-quarter to $206M.

Based on Advantage Investment Management's 13F filing for Q2 2015, filed 27 Mar 2017.